Financials Amvis Holdings, Inc.

Equities

7071

JP3128660002

Healthcare Facilities & Services

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
2,199 ^JPY	-4.56%		-1.48%	-26.82%

2023	Amvis Holdings, Inc. Reports Earnings Results for the Half Year Ended March 31, 2023	CI
2023	Amvis Holdings, Inc.(TSE:7071) added to FTSE All-World Index	CI

Valuation

Fiscal Period: September	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	66,958	195,163	238,528	255,087	215,655	-	-
Enterprise Value (EV) ¹	73,171	196,719	244,619	266,012	230,090	231,725	230,647
P/E ratio	55.3 x	71.7 x	55.4 x	40.4 x	28.8 x	22.1 x	17.4 x
Yield	0.2%	0.11%	0.12%	0.12%	0.18%	0.22%	0.25%
Capitalization / Revenue	7.3 x	12.7 x	10.3 x	7.98 x	5.05 x	3.8 x	3.03 x
EV / Revenue	7.98 x	12.8 x	10.6 x	8.32 x	5.39 x	4.08 x	3.24 x
EV / EBITDA	34.7 x	45.6 x	35.1 x	27.1 x	18.5 x	13.9 x	10.8 x
EV / FCF	-35.5 x	-61.6 x	-73.3 x	-75.7 x	-58.4 x	-99.2 x	145 x
FCF Yield	-2.82%	-1.62%	-1.36%	-1.32%	-1.71%	-1.01%	0.69%
Price to Book	12.8 x	12 x	11.7 x	9.62 x	6.42 x	5.03 x	3.96 x
Nbr of stocks (in thousands)	90,088	96,975	97,757	97,997	98,069	-	-
Reference price ²	743.2	2,012	2,440	2,603	2,199	2,199	2,199
Announcement Date	11/12/20	11/11/21	11/10/22	11/9/23	-	-	-

¹JPY in Million²JPY

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	5,369	9,174	15,334	23,072	31,985	42,677	56,796	71,229
EBITDA ¹	1,097	2,108	4,315	6,966	9,834	12,434	16,655	21,348
EBIT ¹	909	1,826	3,784	6,132	8,630	10,887	14,207	17,925
Operating Margin	16.93%	19.9%	24.68%	26.58%	26.98%	25.51%	25.01%	25.16%
Earnings before Tax (EBT) ¹	858	1,727	3,779	6,060	8,942	10,679	14,000	17,673
Net income ¹	602	1,204	2,627	4,279	6,310	7,497	9,764	12,378
Net margin	11.21%	13.12%	17.13%	18.55%	19.73%	17.57%	17.19%	17.38%
EPS ²	7.532	13.44	28.08	44.03	64.44	76.48	99.59	126.3
Free Cash Flow ¹	-693.9	-2,064	-3,196	-3,336	-3,514	-3,938	-2,336	1,590
FCF margin	-12.92%	-22.5%	-20.84%	-14.46%	-10.99%	-9.23%	-4.11%	2.23%
FCF Conversion (EBITDA)	-	-	-	-	-	-	-	7.45%
FCF Conversion (Net income)	-	-	-	-	-	-	-	12.85%
Dividend per Share ²	0.7500	1.500	2.250	3.000	3.000	4.000	4.833	5.600
Announcement Date	11/13/19	11/12/20	11/11/21	11/10/22	11/9/23	-	-	-

¹JPY in Million²JPY

Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: September	2020 S1	2020 S2	2021 S1	2021 Q4	2021 S2	2022 Q1	2022 Q2	2022 S1	2022 Q3	2022 Q4	2022 S2	2023 Q1	2023 Q2	2023 S1	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 S1	2024 Q3	2024 Q4	2025 Q1	2025 Q2
Net sales ¹	4,082	5,092	6,660	4,610	8,674	5,044	5,347	10,391	6,019	6,662	12,681	7,259	7,483	14,742	8,257	8,986	9,536	10,034	19,500	10,967	11,998	12,800	13,300
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBIT ¹	994	832	1,513	1,270	2,271	1,459	1,426	2,885	1,513	1,734	3,247	1,986	1,951	3,937	2,239	2,454	2,635	2,492	5,050	2,641	2,940	3,200	3,200
Operating Margin	24.35%	16.34%	22.72%	27.55%	26.18%	28.93%	26.67%	27.76%	25.14%	26.03%	25.61%	27.36%	26.07%	26.71%	27.12%	27.31%	27.63%	24.84%	25.9%	24.09%	24.5%	25%	24.06%
Earnings before Tax (EBT) ¹	944	783	1,575	1,224	2,204	1,432	1,379	2,811	1,512	1,737	3,249	1,968	2,372	4,340	2,197	2,405	2,577	2,417	4,950	2,563	2,914	3,100	3,100
Net income ¹	665	539	1,113	820	1,514	1,012	975	1,987	1,068	1,224	2,292	1,398	1,665	3,063	1,551	1,696	1,817	1,679	3,490	1,812	2,050	2,200	2,100
Net margin	16.29%	10.59%	16.71%	17.79%	17.45%	20.06%	18.23%	19.12%	17.74%	18.37%	18.07%	19.26%	22.25%	20.78%	18.78%	18.87%	19.05%	16.73%	17.9%	16.52%	17.08%	17.19%	15.79%
EPS	7.472	-	12.26	-	-	10.42	-	20.46	11.00	-	-	14.29	-	31.30	15.83	-	18.54	-	-	-	-	-	-
Dividend per Share	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Announcement Date	5/14/20	11/12/20	5/13/21	11/11/21	11/11/21	2/10/22	5/12/22	5/12/22	8/10/22	11/10/22	11/10/22	2/9/23	5/11/23	5/11/23	8/9/23	11/9/23	2/8/24	-	-	-	-	-	-

¹JPY in Million

Estimates

Balance Sheet Analysis

Fiscal Period: September	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	-	6,213	1,556	6,091	10,925	14,435	16,070	14,992
Net Cash position ¹	-	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	-	2.948 x	0.3606 x	0.8744 x	1.111 x	1.161 x	0.9649 x	0.7023 x
Free Cash Flow ¹	-694	-2,064	-3,196	-3,336	-3,514	-3,938	-2,336	1,590
ROE (net income / shareholders' equity)	78.4%	38.3%	24.3%	23.3%	26.9%	24.7%	25.5%	25.2%
ROA (Net income/ Total Assets)	-	14.7%	15.6%	16.4%	17.6%	15.6%	16.5%	17.4%
Assets ¹	-	8,173	16,818	26,016	35,952	48,158	59,056	71,139
Book Value Per Share ²	13.40	57.90	168.0	209.0	271.0	343.0	437.0	556.0
Cash Flow per Share ²	9.650	16.40	33.90	52.70	76.70	92.70	112.0	-
Capex ¹	1,185	4,896	5,362	7,118	9,837	12,778	13,685	14,400
Capex / Sales	22.06%	53.37%	34.97%	30.85%	30.76%	29.94%	24.09%	20.22%
Announcement Date	11/13/19	11/12/20	11/11/21	11/10/22	11/9/23	-	-	-

¹JPY in Million²JPY

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Amvis Holdings, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2,199 JPY

Average target price

3,215 JPY

Spread / Average Target

+46.20%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Residential & Long-Term Care

	1st Jan change	Capi.
AMVIS HOLDINGS, INC.	-26.82%	1.37B
ORPEA	-24.26%	2.18B
NATIONAL HEALTHCARE CORPORATION	-1.23%	1.41B
SIENNA SENIOR LIVING INC.	+15.23%	706M
ARVIDA GROUP LIMITED	-2.73%	464M
SONIDA SENIOR LIVING, INC.	+240.37%	432M
MEDITERRANEAN TOWERS LTD.	-7.77%	322M
HUMANA AB	+1.24%	124M
GOLDEN HOUSE LTD	+39.04%	88.82M

Residential & Long-Term Care